Lexpos News

Community pharmacy owners are being asked to share their views on the coming winter and beyond, ahead of the next full Community Pharmacy England Committee meeting which will be held in November. This committee meeting comes at a critical time as the unsustainable pressures on community pharmacies continue through the autumn period, and our Committee [...]

The post Winter Pressures and the Future: Pharmacy Owner Views Sought appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Jext® 300micrograms/0.3ml (1 in 1000) solution for injection auto-injector pen are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP058 Jext® 300micrograms/0.3ml (1 in 1000) solution for injection auto-injector pen at 23.59pm on Friday 27 October 2023. After this [...]

The post Expiry of SSP058 Jext® 300micrograms/0.3ml (1 in 1000) solution for injection auto-injector pen appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (27/10/2023) announced the following list of price concessions for October 2023: Please note the following two lines have been revised upwards following mid-month price changes reported by pharmacy owners, the revised [...]

The post October 2023 Price Concessions 3rd Update appeared first on Community Pharmacy England.

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 November 2023. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item [...]

The post Drug Tariff Watch – November 2023 appeared first on Community Pharmacy England.

Following representations made by Community Pharmacy England, DHSC agreed to the following redeterminations for the September and October 2023 Drug Tariffs: the addition of licensed Omeprazole 1mg/1ml oral suspension sugar free (75ml) to Category C based on Rosemont Pharmaceuticals Ltd the deletion of unlicensed Omeprazole 5mg/5ml oral suspension from Part VIIIB Payment for September and [...]

The post Price redetermination for Omeprazole oral suspension (September and October 2023) appeared first on Community Pharmacy England.